Full Text View
Tabular View
No Study Results Posted
Related Studies
Ventricular Tachyarrhythmia (VT) Storm, Gene Expression in Implantable Cardioverter Defibrillator (ICD) Patients With Electrical Storm
This study is currently recruiting participants.
Study NCT00284453   Information provided by University of Pittsburgh
First Received: January 27, 2006   Last Updated: February 9, 2009   History of Changes

January 27, 2006
February 9, 2009
October 2005
 
 
 
Complete list of historical versions of study NCT00284453 on ClinicalTrials.gov Archive Site
 
 
 
Ventricular Tachyarrhythmia (VT) Storm, Gene Expression in Implantable Cardioverter Defibrillator (ICD) Patients With Electrical Storm
Gene Expression in ICD Patients With Electrical Storm

The purpose of the proposed pilot study is to identify factors which are associated with periods of high ventricular arrhythmia burden. This will be performed by analysis of gene expression from peripheral blood samples.

This is a study of patients with ICD implants who present with multiple shocks, termed electrical storm. The purpose of this pilot study is to identify factors which are associated with periods of high ventricular arrhythmia burden by looking at gene expression from peripheral blood, in addition to levels of known markers of CHF, including catecholamine levels, B-type natriuretic peptide, and troponin. This study hypothesizes that extrinsic or systemic factors play a role in triggering these events, and if true should yield candidate proteins which would spawn functional studies to prove a role in causation. Additionally, identification of a marker of increased recurrence of events may aid in guiding therapy (starting an anti-arrhythmic versus awaiting the next event).

 
Observational
Cohort, Prospective
Arrhythmias
Procedure: Peripheral blood sampling
  • Subjects that have received >2 appropriate ICD shock therapies
  • Subjects that have received >2 inappropriate ICD shock therapies
 

*   Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
 
Recruiting
30
October 2010
 

Inclusion Criteria:

  • ICD patients at least 18 years of age presenting with greater than 2 therapies for ventricular arrhythmias within a 72-hour period
  • Able to give informed consent

Exclusion Criteria:

  • Inability to give informed consent
Both
18 Years and older
No
Contact: Sandeep K. Jain, M.D. 412-647-6272 jainsk@upmc.edu
Contact: Pamela M. White, BSN 412-647-2931 whitepm@upmc.edu
United States
 
NCT00284453
Sandeep Jain, MD, University of Pittsburgh Cardiovascular Institute-Electrophysiology Department
0510087
University of Pittsburgh
 
Principal Investigator: Sandeep K. Jain, M.D. University of Pittsburgh
University of Pittsburgh
February 2009

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP